1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN)

Autor:	Hugues Bourgeois, C. Gourmelon, C. Lefeuvre-Plesse, Xavier Pivot, Thierry Petit, N. Jovenin, C. Korembaum, P. Soibinet, M. Som, A. Brunot, A.L. Septans, Olivier Tredan, L. Campion, M. Robert, M. Adele, M.J. Paillard, J. Martin-babau, M. Campone, Anne Patsouris, Lionel Uwer
Rok vydání:	2015
Předmět:	Eribulin Mesylate Oncology Cancer Research medicine.medical_specialty business.industry Internal medicine medicine Observational study business medicine.disease Toxicity profile Metastatic breast cancer
Zdroj:	European Journal of Cancer. 51:S287
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d70393ef1dc4b944f9154ed3c2b0cbba https://doi.org/10.1016/s0959-8049(16)30815-2 Zobrazit plný text záznamu Full Text from ScienceDirect